Barrett & Company »

Galectin Therapeutics shares owned by Barrett & Company

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Barrett & Company from 13F filings

Historical chart of Barrett & Company investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Barrett & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Barrett & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.2k 3.8k 2.39
2023-12-31 $6.4k 3.8k 1.66
2023-09-30 $9.6k 5.0k 1.92
2023-06-30 $7.2k 5.0k 1.44
2023-03-31 $11k 5.0k 2.10
2022-12-31 $5.6k 5.0k 1.13
2022-09-30 $5.6k 5.0k 1.13